(ELA) Envela - Ratings and Ratios
Exchange: NYSE MKT •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US29402E1029
Luxury Goods, Precious Metals, IT Asset Disposition
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 58.6% |
| Value at Risk 5%th | 86.2% |
| Relative Tail Risk | -10.48% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.29 |
| Alpha | 67.86 |
| CAGR/Max DD | 0.50 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.471 |
| Beta | 0.627 |
| Beta Downside | 0.680 |
| Drawdowns 3y | |
|---|---|
| Max DD | 59.75% |
| Mean DD | 24.80% |
| Median DD | 24.81% |
Description: ELA Envela November 14, 2025
Envela Corporation (NYSE MKT: ELA) operates a two-segment business-Consumer and Commercial-focused on the resale of authenticated high-end luxury items (jewelry, diamonds, watches, bullion) and the end-of-life management of IT assets, including data destruction, refurbishment, and remarketing.
In FY 2023 the company reported roughly $30 million in revenue, a modest uptick from the prior year, with gross margins hovering near 30% on its luxury recommerce operations. The firm’s IT asset disposition (ITAD) segment benefits from tightening data-privacy regulations, a market projected to reach $15 billion by 2025.
The luxury resale market itself is expanding rapidly, with a consensus CAGR of about 12% through 2028, driven by sustainability trends and strong demand from Millennials and Gen Z shoppers who prefer pre-owned premium goods over new purchases.
Envela’s historical roots trace back to 1965 (formerly DGSE Companies) and it is headquartered in Irving, Texas, positioning it within the “Other Specialty Retail” sub-industry under GICS.
For a deeper, data-driven look at Envela’s valuation metrics and peer comparison, you might find the free analytics platform ValueRay worth a quick glance.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (10.2m TTM) > 0 and > 6% of Revenue (6% = 12.5m TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA 2.78pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 22.97% (prev 24.12%; Δ -1.15pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 9.87m <= Net Income 10.2m (YES >=105%, WARN >=100%) |
| Net Debt (-1.46m) to EBITDA (15.3m) ratio: -0.10 <= 3.0 (WARN <= 3.5) |
| Current Ratio 5.19 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (26.0m) change vs 12m ago -0.42% (target <= -2.0% for YES) |
| Gross Margin 23.25% (prev 25.24%; Δ -1.98pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 248.1% (prev 218.1%; Δ 30.06pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 31.50 (EBITDA TTM 15.3m / Interest Expense TTM 429.6k) >= 6 (WARN >= 3) |
Altman Z'' 6.35
| (A) 0.53 = (Total Current Assets 59.4m - Total Current Liabilities 11.5m) / Total Assets 90.9m |
| (B) 0.28 = Retained Earnings (Balance) 25.4m / Total Assets 90.9m |
| (C) 0.16 = EBIT TTM 13.5m / Avg Total Assets 84.2m |
| (D) 0.86 = Book Value of Equity 25.7m / Total Liabilities 29.9m |
| Total Rating: 6.35 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 69.54
| 1. Piotroski 5.0pt |
| 2. FCF Yield 3.06% |
| 3. FCF Margin 3.96% |
| 4. Debt/Equity 0.38 |
| 5. Debt/Ebitda -0.10 |
| 6. ROIC - WACC (= 7.34)% |
| 7. RoE 18.01% |
| 8. Rev. Trend 36.65% |
| 9. EPS Trend -26.61% |
What is the price of ELA shares?
As of December 01, 2025, the stock is trading at USD 11.53 with a total of 32,734 shares traded.
Over the past week, the price has changed by +7.36%, over one month by +26.84%, over three months by +53.12% and over the past year by +73.12%.
Over the past week, the price has changed by +7.36%, over one month by +26.84%, over three months by +53.12% and over the past year by +73.12%.
Is ELA a buy, sell or hold?
Envela has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy ELA.
- Strong Buy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ELA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13 | 12.7% |
| Analysts Target Price | 13 | 12.7% |
| ValueRay Target Price | 13.4 | 15.9% |
ELA Fundamental Data Overview November 25, 2025
Market Cap USD = 272.4m (272.4m USD * 1.0 USD.USD)
P/E Trailing = 26.8974
P/S = 1.3042
P/B = 4.46
Beta = 0.251
Revenue TTM = 208.8m USD
EBIT TTM = 13.5m USD
EBITDA TTM = 15.3m USD
Long Term Debt = 9.54m USD (from longTermDebt, last quarter)
Short Term Debt = 4.79m USD (from shortTermDebt, last quarter)
Debt = 23.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.46m USD (from netDebt column, last quarter)
Enterprise Value = 270.9m USD (272.4m + Debt 23.0m - CCE 24.4m)
Interest Coverage Ratio = 31.50 (Ebit TTM 13.5m / Interest Expense TTM 429.6k)
FCF Yield = 3.06% (FCF TTM 8.28m / Enterprise Value 270.9m)
FCF Margin = 3.96% (FCF TTM 8.28m / Revenue TTM 208.8m)
Net Margin = 4.89% (Net Income TTM 10.2m / Revenue TTM 208.8m)
Gross Margin = 23.25% ((Revenue TTM 208.8m - Cost of Revenue TTM 160.3m) / Revenue TTM)
Gross Margin QoQ = 22.77% (prev 22.57%)
Tobins Q-Ratio = 2.98 (Enterprise Value 270.9m / Total Assets 90.9m)
Interest Expense / Debt = 0.46% (Interest Expense 105.8k / Debt 23.0m)
Taxrate = 22.46% (972.5k / 4.33m)
NOPAT = 10.5m (EBIT 13.5m * (1 - 22.46%))
Current Ratio = 5.19 (Total Current Assets 59.4m / Total Current Liabilities 11.5m)
Debt / Equity = 0.38 (Debt 23.0m / totalStockholderEquity, last quarter 61.1m)
Debt / EBITDA = -0.10 (Net Debt -1.46m / EBITDA 15.3m)
Debt / FCF = -0.18 (Net Debt -1.46m / FCF TTM 8.28m)
Total Stockholder Equity = 56.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.22% (Net Income 10.2m / Total Assets 90.9m)
RoE = 18.01% (Net Income TTM 10.2m / Total Stockholder Equity 56.7m)
RoCE = 20.44% (EBIT 13.5m / Capital Employed (Equity 56.7m + L.T.Debt 9.54m))
RoIC = 15.05% (NOPAT 10.5m / Invested Capital 69.7m)
WACC = 7.71% (E(272.4m)/V(295.3m) * Re(8.33%) + D(23.0m)/V(295.3m) * Rd(0.46%) * (1-Tc(0.22)))
Discount Rate = 8.33% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.03%
[DCF Debug] Terminal Value 76.76% ; FCFE base≈6.92m ; Y1≈6.70m ; Y5≈6.67m
Fair Price DCF = 4.33 (DCF Value 112.5m / Shares Outstanding 26.0m; 5y FCF grow -4.35% → 3.0% )
EPS Correlation: -26.61 | EPS CAGR: 7.25% | SUE: 3.06 | # QB: 3
Revenue Correlation: 36.65 | Revenue CAGR: 7.30% | SUE: 0.70 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.08 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS current Year (2025-12-31): EPS=0.41 | Chg30d=+0.060 | Revisions Net=+2 | Growth EPS=+59.6% | Growth Revenue=+17.9%
EPS next Year (2026-12-31): EPS=0.41 | Chg30d=+0.035 | Revisions Net=+2 | Growth EPS=+0.0% | Growth Revenue=+2.5%
P/E Trailing = 26.8974
P/S = 1.3042
P/B = 4.46
Beta = 0.251
Revenue TTM = 208.8m USD
EBIT TTM = 13.5m USD
EBITDA TTM = 15.3m USD
Long Term Debt = 9.54m USD (from longTermDebt, last quarter)
Short Term Debt = 4.79m USD (from shortTermDebt, last quarter)
Debt = 23.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.46m USD (from netDebt column, last quarter)
Enterprise Value = 270.9m USD (272.4m + Debt 23.0m - CCE 24.4m)
Interest Coverage Ratio = 31.50 (Ebit TTM 13.5m / Interest Expense TTM 429.6k)
FCF Yield = 3.06% (FCF TTM 8.28m / Enterprise Value 270.9m)
FCF Margin = 3.96% (FCF TTM 8.28m / Revenue TTM 208.8m)
Net Margin = 4.89% (Net Income TTM 10.2m / Revenue TTM 208.8m)
Gross Margin = 23.25% ((Revenue TTM 208.8m - Cost of Revenue TTM 160.3m) / Revenue TTM)
Gross Margin QoQ = 22.77% (prev 22.57%)
Tobins Q-Ratio = 2.98 (Enterprise Value 270.9m / Total Assets 90.9m)
Interest Expense / Debt = 0.46% (Interest Expense 105.8k / Debt 23.0m)
Taxrate = 22.46% (972.5k / 4.33m)
NOPAT = 10.5m (EBIT 13.5m * (1 - 22.46%))
Current Ratio = 5.19 (Total Current Assets 59.4m / Total Current Liabilities 11.5m)
Debt / Equity = 0.38 (Debt 23.0m / totalStockholderEquity, last quarter 61.1m)
Debt / EBITDA = -0.10 (Net Debt -1.46m / EBITDA 15.3m)
Debt / FCF = -0.18 (Net Debt -1.46m / FCF TTM 8.28m)
Total Stockholder Equity = 56.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.22% (Net Income 10.2m / Total Assets 90.9m)
RoE = 18.01% (Net Income TTM 10.2m / Total Stockholder Equity 56.7m)
RoCE = 20.44% (EBIT 13.5m / Capital Employed (Equity 56.7m + L.T.Debt 9.54m))
RoIC = 15.05% (NOPAT 10.5m / Invested Capital 69.7m)
WACC = 7.71% (E(272.4m)/V(295.3m) * Re(8.33%) + D(23.0m)/V(295.3m) * Rd(0.46%) * (1-Tc(0.22)))
Discount Rate = 8.33% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.03%
[DCF Debug] Terminal Value 76.76% ; FCFE base≈6.92m ; Y1≈6.70m ; Y5≈6.67m
Fair Price DCF = 4.33 (DCF Value 112.5m / Shares Outstanding 26.0m; 5y FCF grow -4.35% → 3.0% )
EPS Correlation: -26.61 | EPS CAGR: 7.25% | SUE: 3.06 | # QB: 3
Revenue Correlation: 36.65 | Revenue CAGR: 7.30% | SUE: 0.70 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.08 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS current Year (2025-12-31): EPS=0.41 | Chg30d=+0.060 | Revisions Net=+2 | Growth EPS=+59.6% | Growth Revenue=+17.9%
EPS next Year (2026-12-31): EPS=0.41 | Chg30d=+0.035 | Revisions Net=+2 | Growth EPS=+0.0% | Growth Revenue=+2.5%
Additional Sources for ELA Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle